Back to Cubist Systematic Strategies, LLC Cubist Systematic Strategies, LLC

ARQT

17 quarters

Position history for Cubist Systematic Strategies, LLCCubist Systematic Strategies, LLC's holdings in Arcutis Biotherapeutics, Inc.

As of its last 13F, for Q3 2025, Cubist Systematic Strategies held 66,080 shares of ARQT (Arcutis Biotherapeutics), worth $1.2M. It opened the position in Q3 2025.

Current Value

$1.2M

Current Shares

66,080

Total Value Change

+$1.2M

Total Shares Change

+64,673

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q3
Latest
New
66,080
-
$1.2M0.0%$18.85
35
2025-Q1
Exited
0
-100.0%
$00.0%$15.64
0
2024-Q4
New
128,248
-
$1.8M0.0%$13.93
36
2024-Q2
Exited
0
-100.0%
$00.0%$9.30
0
2024-Q1
Decreased
20,705
-80.7%
$205,1870.0%$9.91
0
2023-Q4
New
107,168
-
$346,1530.0%$3.23
33
2023-Q1
Exited
0
-100.0%
$00.0%$11.00
0
2022-Q4
Increased
84,022
+8395.6%
$1.2M0.0%$14.80
41
2022-Q3
Decreased
989
-98.0%
$19,0000.0%$19.11
0
2022-Q2
Increased
49,047
+646.6%
$1M0.0%$21.31
40
2022-Q1
Decreased
6,569
-52.4%
$127,0000.0%$19.26
0
2021-Q4
Increased
13,785
+945.1%
$286,0000.0%$20.74
38
2021-Q3
Decreased
1,319
-49.7%
$32,0000.0%$23.89
0
2021-Q2
Decreased
2,622
-81.0%
$72,0000.0%$27.29
0
2021-Q1
Increased
13,769
+706.1%
$398,0000.0%$28.93
38
2020-Q4
Increased
1,708
+21.4%
$48,0000.0%$28.13
24
2020-Q3
New
1,407
-
$41,0000.0%$29.30
28

Other major holders of ARQT: BlackRock, Inc., Jennison Associates LLC, FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used